Raymond James & Associates’s Exicure XCUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-503
Closed -$15K 4243
2022
Q1
$15K Hold
503
﹤0.01% 4040
2021
Q4
$15K Hold
503
﹤0.01% 4052
2021
Q3
$91K Buy
503
+86
+21% +$17.4K ﹤0.01% 3845
2021
Q2
$94K Hold
417
﹤0.01% 3845
2021
Q1
$136K Hold
417
﹤0.01% 3718
2020
Q4
$111K Buy
417
+134
+47% +$33.5K ﹤0.01% 3540
2020
Q3
$74K Sell
283
-2
-0.7% -$653 ﹤0.01% 3414
2020
Q2
$104K Buy
285
+2
+0.7% +$725 ﹤0.01% 3278
2020
Q1
$63K Buy
283
+83
+42% +$26.3K ﹤0.01% 3290
2019
Q4
$86K Hold
200
﹤0.01% 3493
2019
Q3
$76K Buy
+200
New +$76.5K ﹤0.01% 3424

Other funds holding XCUR

Raymond James & Associates's XCUR Position: Q2 2022 in Review

Raymond James & Associates sold out of Exicure (XCUR) in Q2 2022, closing a stake of 503 shares — an estimated $15K sold.

Raymond James & Associates first reported a position in XCUR in Q3 2019 and held it in 11 quarters. The position peaked at $136K in Q1 2021. 18 funds tracked by Wall St. Rank hold XCUR as of Q2 2022.

  • Raymond James & Associates reported no remaining Exicure position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 503 Exicure shares in Q2 2022, an estimated $15K.
  • Raymond James & Associates first reported a position in Exicure in Q3 2019 and held it in 11 quarters.
  • Raymond James & Associates's Exicure position peaked at $136K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Exicure as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.